Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Metrics to compare | TTRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTTRXPeersSector | |
---|---|---|---|---|
P/E Ratio | −81.6x | −3.9x | −0.7x | |
PEG Ratio | 1.50 | 0.02 | 0.00 | |
Price/Book | 117.7x | 1.7x | 2.6x | |
Price / LTM Sales | - | 128.7x | 3.4x | |
Upside (Analyst Target) | - | 124.9% | 38.0% | |
Fair Value Upside | Unlock | 12.8% | 5.3% | Unlock |